Clinical update on the use of recombinant factor VII.
Glazer
S
S
Biopharmaceuticals Division, Novo Nordisk A/S, Gentofte, Denmark.
Hedner
U
U
Falch
J F
JF
D005167:Factor VII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000628:therapy*
D011994:Recombinant Proteins; D005167:Factor VII